105 related articles for article (PubMed ID: 38742830)
1. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 Jun; 15(6):e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
2. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
3. Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M; Zolnik CP; Castle PE; Porras C; Herrero R; Gradissimo A; Gonzalez P; Safaeian M; Schiffman M; Burk RD;
PLoS Pathog; 2020 Mar; 16(3):e1008376. PubMed ID: 32214382
[TBL] [Abstract][Full Text] [Related]
4. Sexual transmission of murine papillomavirus (MmuPV1) in
Spurgeon ME; Lambert PF
Elife; 2019 Oct; 8():. PubMed ID: 31621578
[TBL] [Abstract][Full Text] [Related]
5. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
6. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
[TBL] [Abstract][Full Text] [Related]
7. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
8. Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types.
Huang X; Li C; Li F; Zhao J; Wan X; Wang K
Int J Cancer; 2018 Aug; 143(3):621-634. PubMed ID: 29479697
[TBL] [Abstract][Full Text] [Related]
9. Role of next-generation sequencing in understanding the interactions between human papillomavirus and the cervicovaginal microbiome.
Cervantes JL; Hong BY
Gynecol Obstet Invest; 2013; 76(4):195-202. PubMed ID: 23711875
[TBL] [Abstract][Full Text] [Related]
10. Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.
Hu J; Budgeon LR; Cladel NM; Balogh K; Myers R; Cooper TK; Christensen ND
J Gen Virol; 2015 Dec; 96(12):3554-3565. PubMed ID: 26399579
[TBL] [Abstract][Full Text] [Related]
11. Vaginal flora in HPV infection: a cross‑sectional analysis.
Dou P; Fang F; Qin R; Nie J; Chen X; Yin X; Wang Y; Shi S
J Obstet Gynaecol; 2024 Dec; 44(1):2361847. PubMed ID: 38861397
[TBL] [Abstract][Full Text] [Related]
12. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
13. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
14. Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study.
Molina MA; Leenders WPJ; Huynen MA; Melchers WJG; Andralojc KM
BMC Infect Dis; 2024 Jun; 24(1):552. PubMed ID: 38831406
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
Gunder LC; Blaine-Sauer S; Johnson HR; Shin MK; Auyeung AS; Zhang W; Leverson GE; Ward-Shaw ET; King RE; McGregor SM; Matkowskyj KA; Lambert PF; Carchman EH
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893697
[TBL] [Abstract][Full Text] [Related]
16. The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status.
Vargas-Robles D; Romaguera J; Alvarado-Velez I; Tosado-Rodríguez E; Dominicci-Maura A; Sanchez M; Wiggin KJ; Martinez-Ferrer M; Gilbert JA; Forney LJ; Godoy-Vitorino F
mSystems; 2023 Aug; 8(4):e0035723. PubMed ID: 37534938
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
Kaelin EA; Skidmore PT; Łaniewski P; Holland LA; Chase DM; Herbst-Kralovetz MM; Lim ES
mSystems; 2022 Apr; 7(2):e0006422. PubMed ID: 35343798
[TBL] [Abstract][Full Text] [Related]
18. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection.
Zhang N; Chen Z; Huang M; Lu Q; Yang H; Xiang J; Yang J; Peng Y; Wang G; Han N; Min X; Huang J
J Med Virol; 2024 Feb; 96(2):e29451. PubMed ID: 38305046
[TBL] [Abstract][Full Text] [Related]
20. A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
PLoS One; 2015; 10(3):e0120128. PubMed ID: 25803616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
